Navigation Links
Senetek PLC Launches Dedicated Pyratine-6(TM) Website
Date:1/27/2009

NAPA, Calif., Jan. 27 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that target the science of healthy aging, announced today the launch of a dedicated Pyratine-6(TM) website, http://www.Pyratine-6.com, that provides information to consumers and medical professionals about Pyratine-6, Senetek's advanced cytokinin technology.

The website (http://www.Pyratine-6.com) is a comprehensive and convenient resource for information on Senetek's anti-aging cytokinin technology and the Pyratine-6(TM) product line, which includes Pyratine-6(TM) Lotion, Creme, Foaming Cleanser, Soft Creme + 10% Vitamin C. An SPF product will be introduced in Spring 2009 to complete the Pyratine-6(TM) line.

Detailed sections provide site visitors with a scientific analysis of cytokinins for therapeutic applications, and present the results of a 12-week independent clinical trial that demonstrates the efficacy of Pyratine-6(TM) for roughness, erythema, hyperpigmentation, skin moisture, and fine wrinkles. Also featured is Senetek's history in the development of innovative skincare technologies, including the cytokinins Kinetin and Zeatin. Additionally, a dedicated physician-only section will soon provide local resources, staff training tools and sales support to the medical community.

"The launch of the Pyratine-6(TM) website allows both consumers and physicians practical, reliable access to cutting-edge anti-aging information and products from Senetek," said Frank Massino, CEO of Senetek PLC. "The straightforward design of the site echoes and supports our research-based, results-driven technology."

About Senetek, PLC

Senetek PLC (OTCBB:SNKTY) is a life sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of kinetin, the best-selling anti-aging product sold in the North American physician market. For more information, visit the company's website at http://www.senetekplc.com.


'/>"/>
SOURCE Senetek PLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Senetek PLC Announces Positive Results from Pyratine-6(TM) Clinical Trial in Patients with Acne Rosacea
2. Mission Pharmacal Launches CitraNatal(R) Assure Prescription Prenatal Vitamin
3. Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer
4. Isogen Launches Major New Facility to Address Global Biopharma Demand
5. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
6. Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children
7. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
8. Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients
9. Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center
10. Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss
11. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... KEY FINDINGS North America ... market in 2016 and is expected to continue in ... a large number of surgical procedures that are taking ... in the patient temperature management market.) Patient warming and ... of blood during surgeries, lowering the risks of neurological ...
(Date:12/8/2016)... INDIANAPOLIS , Dec. 8, 2016  Eli Lilly ... detailed results of its phase 3 EXPEDITION3 trial at ... (CTAD) meeting. As previously disclosed, solanezumab did not meet ... study of solanezumab initiated in people with mild dementia ... pursue regulatory submissions for solanezumab for the treatment of ...
(Date:12/8/2016)... , 8 de dezembro de 2016  A Mederi Therapeutics Inc . ... um tratamento não cirúrgico para a doença do refluxo gastroesofágico (DRGE). ... ... Live Stretta procedure performed and broadcast during ... at Wuhan Union Hospital ...
Breaking Medicine Technology:
(Date:12/8/2016)... Pa. (PRWEB) , ... December 08, 2016 , ... ... Medicine Southern Chester County, a Property owned by an affiliate of Seavest, has ... square foot Penn Medicine Southern Chester County ambulatory care center (ACC) was named ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental ... dentists and patients about the safety issues related to dental restorations. According to the ... is projected to reach $6.4 billion in 2018 with more than 30 million Americans ...
(Date:12/8/2016)... Tampa, Fla (PRWEB) , ... December 08, 2016 ... ... offering smarter modes of access for customers and employees that are both engaging ... ChangeGear 7 with Service Smart Technology, the software company revealed today its plans ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... has been recognized for adherence to the highest standards of trauma, maternity, cancer ... announced the center's president and CEO, Dr. Daniel Messina. , Among the recognitions, ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s ... possible. With this in mind, SIGVARIS has created a new line of anti-embolism ... bed rest and provide the benefits of graduated compression when transitioning from recovery ...
Breaking Medicine News(10 mins):